Possible regulation of ganglioside GD3 synthase gene expression with DNA methylation in human glioma cells

Glycoconj J. 2023 Jun;40(3):323-332. doi: 10.1007/s10719-023-10108-9. Epub 2023 Mar 10.

Abstract

Gangliosides are expressed in nervous systems and some neuroectoderm-derived tumors at high levels and play pivotal roles. However, mechanisms for the regulation of glycosyltransferase genes responsible for the ganglioside synthesis are not well understood. In this study, we analyzed DNA methylation patterns of promoter regions of GD3 synthase (ST8SIA1) as well as mRNA levels and ganglioside expression using human glioma cell lines. Among 5 cell lines examined, 4 lines showed changes in the expression levels of related genes after treatment with 5-aza-dC. LN319 showed up-regulation of St8sia1 and increased b-series gangliosides after 5-aza-dC treatment, and an astrocytoma cell line, AS showed high expression of ST8SIA1 and b-series gangliosides persistently before and after 5-Aza-2'-deoxycytidine treatment. Using these 2 cell lines, DNA methylation patterns of the promoter regions of the gene were analyzed by bisulfite-sequencing. Consequently, 2 regions that were methylated before 5-Aza-2'-deoxycytidine treatment were demethylated in LN319 after the treatment, while those regions were persistently demethylated in AS. These 2 regions corresponded with sites defined as promoter regions by Luciferase assay. Taken together, it was suggested that ST8SIA1 gene is regulated by DNA methylation at the promoter regions, leading to the regulation of tumor phenotypes.

Keywords: Ganglioside; Glioma; Methylation; Promoter; Regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / metabolism
  • Azacitidine / pharmacology
  • Cell Line, Tumor
  • DNA Methylation* / genetics
  • Decitabine / metabolism
  • Decitabine / pharmacology
  • Gangliosides / genetics
  • Gangliosides / metabolism
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Glioma* / genetics
  • Glioma* / metabolism
  • Glioma* / pathology
  • Humans
  • Promoter Regions, Genetic / genetics

Substances

  • Azacitidine
  • Decitabine
  • ganglioside, GD3
  • Gangliosides
  • alpha-N-acetylneuraminate alpha-2,8-sialyltransferase